Join
Live feed
·
INSIDERFilingvia Quantisnow
Halozyme Therapeutics Inc. logo

SVP, CHIEF FINANCIAL OFFICER Labrosse Nicole converted options into 23,773 shares and covered exercise/tax liability with 12,894 shares, increasing direct ownership by 49% to 32,958 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HALO (Halozyme Therapeutics Inc.) and more on Quantisnow.